June 22 (Reuters) – Antengene Corp Ltd: * ENTERS EXCLUSIVE LICENSE AGREEMENT WITH K2 THERAPEUTICS FOR ATG-106 * TO RECEIVE ABOUT $20 MILLION UPFRONT AND NEAR-TERM CONSIDERATION Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Microsoft is winding down Oracle deal to rent AI cloud capacity, Bloomberg News reports
Nov 6 (Reuters) - Microsoft is winding down an arrangement to rent AI computing from…
As tech swoon roils market, US inflation data on tap
By Lewis Krauskopf NEW YORK, Nov 6 (Reuters) - Jolted investors head into next week…
Olympic champion Khelif set for first bout since Paris Games on December 15
VIDEO SHOWS: ARCHIVE OF ALGERIAN BOXER IMANE KHELIF SHOWS: PARIS, FRANCE (ARCHIVE - AUGUST 9,…
